Randomized, Double-Blind, Placebo-Controlled Evaluation of the Tolerability of Two Civamide (Zucapsaicin) Patch Strengths Compared to Placebo Patch in Healthy Volunteers.

Trial Profile

Randomized, Double-Blind, Placebo-Controlled Evaluation of the Tolerability of Two Civamide (Zucapsaicin) Patch Strengths Compared to Placebo Patch in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 09 Jun 2011

At a glance

  • Drugs Zucapsaicin (Primary)
  • Indications Pain; Postherpetic neuralgia
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Winston Laboratories
  • Most Recent Events

    • 10 Feb 2009 Status changed from active, no longer recruiting to completed as reported by Winston Pharmaceuticals.
    • 10 Feb 2009 Positive top-line results reported by Winston Pharmaceuticals.
    • 05 Jan 2009 Planned end date changed from 1 Nov 2008 to 1 Jan 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top